Mycoplasma pneumoniae (MP) enfeksiyonu ile ilişkili mukokütanöz döküntüler, MP’nin neden olduğu döküntü ve mukozit olarak tanımlanan yeni bir terimle açıklanmaktadır. Amoksisilin-klavulanik asit’in ilk dozundan sonra, 17 yaşındaki bir erkek çocuğunda döküntü, iki taraflı pürülan konjonktivit, ağız ve genital ülserler gelişmiş ve hastaya ilaç alerjisi ön tanısı konulmuştur. Hasta, Stevens-Johnson sendromu ön tanısıyla hastaneye yatırılıp, sistemik steroid tedavisine başlanmıştır. Takip sürecinde, hastada laboratuvar testleri ile doğrulanan MP nedenli pnömoni gelişmiş ve hastaya MP’nin neden olduğu döküntü ve mukozit tanısı konulmuştur. Hasta, azitromisin ve intravenöz immünoglobulin tedavisi ile iki hafta içinde tamamen iyileşmiştir. Bu olguda, ilaç alerjisi ayırıcı tanısında dikkate alınması gereken MP’nin neden olduğu döküntü ve mukozitli bir olguyu tartışmayı ve bu duruma dair farkındalığı artırmayı amaçladık.
Mucocutaneous eruptions associated with Mycoplasma pneumoniae (MP) infection has been newly termed ‘MP-induced rash and mucositis (MIRM)’. A 17-year-old male developed a rash, bilateral purulent conjunctivitis, and oral and genital ulcers after the first dose of amoxicillin-clavulanic acid, initially considered as a drug allergy. Following hospitalization under a preliminary diagnosis of Stevens-Johnson syndrome and initiation of systemic steroids, he developed pneumonia. Laboratory tests confirmed MP infection, leading to a refined diagnosis of MIRM. The patient fully recovered within two weeks following treatment with azithromycin and intravenous immunoglobulin. This case underscores the importance of considering MIRM in the differential diagnosis of drug allergies and aims to enhance awareness of this condition.
Primary Language | English |
---|---|
Subjects | Clinical Sciences (Other) |
Journal Section | CASE REPORTS |
Authors | |
Early Pub Date | September 20, 2024 |
Publication Date | |
Submission Date | June 11, 2024 |
Acceptance Date | August 5, 2024 |
Published in Issue | Year 2024 Articles Online First |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.